WO2023077489A1 - Mnp marker combination of yersinia pestis, primer pair combination, kit, and application thereof - Google Patents

Mnp marker combination of yersinia pestis, primer pair combination, kit, and application thereof Download PDF

Info

Publication number
WO2023077489A1
WO2023077489A1 PCT/CN2021/129167 CN2021129167W WO2023077489A1 WO 2023077489 A1 WO2023077489 A1 WO 2023077489A1 CN 2021129167 W CN2021129167 W CN 2021129167W WO 2023077489 A1 WO2023077489 A1 WO 2023077489A1
Authority
WO
WIPO (PCT)
Prior art keywords
mnp
marker
yersinia pestis
pestis
combination
Prior art date
Application number
PCT/CN2021/129167
Other languages
French (fr)
Chinese (zh)
Inventor
万人静
高利芬
方治伟
陈利红
肖华峰
李甜甜
李论
周俊飞
彭海
Original Assignee
江汉大学
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 江汉大学 filed Critical 江汉大学
Priority to PCT/CN2021/129167 priority Critical patent/WO2023077489A1/en
Publication of WO2023077489A1 publication Critical patent/WO2023077489A1/en

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions
    • C12Q1/6858Allele-specific amplification
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/20Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
    • G16B25/20Polymerase chain reaction [PCR]; Primer or probe design; Probe optimisation
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B30/00ICT specially adapted for sequence analysis involving nucleotides or amino acids
    • G16B30/10Sequence alignment; Homology search
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B50/00ICT programming tools or database systems specially adapted for bioinformatics
    • G16B50/30Data warehousing; Computing architectures
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Definitions

  • the embodiment of the present invention relates to the field of biotechnology, in particular to a MNP marker combination of Yersinia pestis, a primer pair combination, a kit and applications thereof.
  • Yersinia pestis belongs to the genus Yersinia, it is the pathogenic bacteria that causes the severe infectious disease plague, and it is also one of the deadly bacterial warfare agents. Plague is a Class A infectious disease stipulated in my country's Law on the Prevention and Control of Infectious Diseases. It is highly contagious and fatal. People are infected through contact with infected animals, eating contaminated food, or being bitten by rats and fleas.
  • Yersinia pestis is a group organism, and in the interaction with the host and the environment, individuals in the Yersinia pestis group often mutate, resulting in the failure of detection methods and prevention methods; for laboratory research on Yersinia pestis, this Variation can also cause strains with the same name in different laboratories or in different periods of the same laboratory to be actually different, resulting in non-reproducible and non-comparable experimental results. Therefore, the development of a rapid, accurate, and variable-monitoring detection and analysis method for Yersinia pestis is of great significance for the scientific research and epidemic prevention of Yersinia pestis.
  • Classical detection methods of Yersinia pestis including isolation and culture, PCR technology, whole genome and metagenomic sequencing, etc., have one or more limitations in terms of time length, operational complexity, detection throughput, accuracy and sensitivity of detection of mutations, and cost.
  • the targeted molecular marker detection technology that combines ultra-multiplex PCR amplification and high-throughput sequencing can enrich target microorganisms in samples with low microbial content, avoiding a large amount of data waste and background caused by whole genome and metagenomic sequencing Noise, which has the advantages of less sample requirement, accurate diagnosis results, saving data volume, and detecting low-frequency variation.
  • the molecular markers detected by the existing targeted molecular marker detection technology mainly include SNP and SSR markers.
  • SSR markers are recognized as the most polymorphic markers, but their number is small in microorganisms; SNP markers are huge in number, densely distributed, and are dimorphic markers, and the polymorphism of a single SNP marker is not enough to capture potential alleles in microbial populations genetic diversity. Therefore, the development of new molecular markers with high polymorphism and their detection technology has become an urgent technical problem to be solved.
  • MNP markers refer to polymorphic markers caused by multiple nucleotides in an upper region of the genome. Compared with SSR markers and SNP markers, MNP markers have the following advantages: (1) rich allelic types, with 2 n allele types on a single MNP marker, higher than SSR and SNP markers; (2) strong species discrimination ability , only a small amount of MNP markers are needed to achieve species identification, reducing the detection error rate.
  • the MNP marker method based on ultra-multiplex PCR combined with next-generation high-throughput sequencing technology to detect MNP markers has the following advantages: (1) The output is base sequence, without parallel experiments, and a standardized database can be constructed for sharing; (2) High Efficiency, using sample DNA barcodes, breaking through the limitation of the number of sequencing samples, and can type tens of thousands of MNP markers in hundreds of samples at one time; (3) High sensitivity, using multiplex PCR to detect multiple targets at a time, avoiding single Target amplification failures lead to high false negatives and low sensitivity; (4) high accuracy, using a second-generation high-throughput sequencer to sequence the amplified product hundreds of times.
  • MNP marker and its detection technology MNP marker method can realize the classification and traceability of multi-allelic genotypes in populations, and has application potential in the identification of pathogenic microorganisms, fingerprint database construction, and genetic variation detection.
  • MNP marker and detection primers for the pathogenic microorganism Yersinia pestis.
  • the combination of markers and primers developed in the present invention will be used to formulate national standards for pathogen detection (plan number 20201830-T-469), which will be released by the end of 2021.
  • the purpose of the present invention is to provide a MNP marker combination, primer pair combination, kit and application of Yersinia pestis, which can identify and detect mutations of Yersinia pestis, and have the effects of multi-target, high throughput, high sensitivity and fine typing .
  • the MNP markers refer to the MNP markers that are screened on the Yersinia pestis genome to distinguish them from other species and have multiple nucleotide polymorphisms within the species
  • the MNP marker combination includes 15 markers from MNP-1 to MNP-15 on the reference sequence of Yersinia pestis AL590842.
  • the multiple PCR primer pair combination includes 15 pairs of primers, and the specific primer sequences are as SEQ ID NO.1- Shown in SEQ ID NO.30.
  • each MNP-labeled primer includes an upper primer and a lower primer, as shown in Table 1 of the specification.
  • a detection kit for detecting the Y. pestis MNP marker combination includes the primer pair combination.
  • kit also includes a multiplex PCR master mix.
  • the kit of the present invention to carry out the first round of multiplex PCR amplification to the total DNA and the blank control, and the number of cycles is not higher than 25;
  • the amplified product is purified, add sample tags and next-generation sequencing adapters based on the second round of PCR amplification; quantify the second-round amplified product after purification; detect multiple strains by combining the second-round amplified product, etc.
  • High-throughput sequencing was carried out after the amounts were mixed; the sequencing results were compared to the reference sequence of Yersinia pestis, and the number of detected sequences and genotype data in the total DNA were obtained.
  • the quality control scheme and determination method use the DNA of Yersinia pestis with a known copy number as the detection sample, evaluate the sensitivity, accuracy and specificity of the kit to detect Yersinia pestis, and formulate the kit to detect plague The quality control scheme and determination method for bacillus.
  • the detection of genetic variation between strains includes using the above kit and method to obtain the genotype data of each of the 15 MNP markers of the strains to be compared. Through genotype comparison, analyze whether there are differences in the main genotypes of the strains to be compared on the 15 MNP markers. If there is a variation in at least one main genotype of the MNP marker in the strain to be compared, it is determined that there is a genetic variation between the two. As an alternative, it is also possible to amplify the 15 markers of the strain to be compared by single-plex PCR, and then perform Sanger sequencing on the amplified products.
  • the sequence After obtaining the sequence, compare the genotype of each MNP marker of the strain to be compared. right. If there are MNP markers with inconsistent main genotypes, there is variation among the strains to be compared. When detecting the genetic variation within the strain, it is judged by statistical model whether the MNP markers in the strain to be tested detect sub-genotypes other than the main genotype. If the strain to be tested has a subgenotype at least one MNP marker, it is determined that there is genetic variation within the strain to be tested.
  • the genotype data of the MNP marker of the Yersinia pestis identified from the sample is entered into the database file to form the DNA fingerprint database of the Yersinia pestis; when different samples are identified each time, by Compared with the DNA fingerprint database of Yersinia pestis, identify whether the Yersinia pestis in the sample and the strains in the database have a main genotype (a genotype supported by more than 50% sequencing fragments in an MNP marker) at the MNP marker Differences, Yersinia pestis with major genotype differences in at least one MNP marker is a new variant type, which is included in the DNA fingerprint database.
  • Yersinia pestis typing When used for Yersinia pestis typing, it is to identify the Yersinia pestis in the sample to be tested, and obtain the genotype of each MNP site; collect the genome sequence of Yersinia pestis published on the Internet and the constructed DNA fingerprint database of Yersinia pestis Constitute the reference sequence library of Yersinia pestis; compare the genotype of Yersinia pestis in the sample to be tested with the reference sequence library of Yersinia pestis, screen the genetically consistent or closest strains, and obtain the type of Yersinia pestis in the sample to be tested . According to the comparison result with the reference sequence library, it is identified whether the Yersinia pestis in the sample is an existing type or a new variant, and the fine typing of the Yersinia pestis is realized.
  • the present invention has the following advantages:
  • the invention provides a MNP marker combination of Yersinia pestis, a primer pair combination, a kit and applications thereof.
  • the provided 15 MNP markers of Yersinia pestis and their primer combinations can be used for multiplex PCR amplification, and the next-generation sequencing platform can be used to sequence the amplified products, which meets the needs of high-throughput, high-efficiency, high-accuracy and
  • the demand for high-sensitivity detection meets the requirements for the construction of standard and shareable fingerprint data for Y. pestis; the need for accurate detection of genetic variation among Y. pestis strains; the need for identifying homozygous and heterozygous Y. pestis.
  • the present invention is the first in the field of Yersinia pestis, and there are no related literature reports; MNP markers are mainly developed based on reference sequences, and according to the resequencing data of the reported Yersinia pestis representative races, large-scale identifications of Yersinia pestis species, which are different from other species, can be mined MNP markers with polymorphic and conserved sequences on both sides of the species; MNP marker detection primers suitable for multiplex PCR amplification can be designed through the conserved sequences on both sides of the MNP markers; and a set of multiple A set of MNP markers with the largest morphism and high specificity, the most compatible primer combination and detection method, and used in the detection of Yersinia pestis, the construction of DNA fingerprints, the detection of genetic variation within and between strains and other related applications, Provide technical support for scientific research, scientific monitoring and control of Yersinia pestis.
  • Figure 1 is a schematic diagram of MNP marker polymorphism
  • Fig. 2 is the screening and primer design flowchart of Yersinia pestis MNP marker
  • Fig. 3 is the detection flowchart of MNP mark
  • the genome sequence information of representative races of the microbial species to be detected can also be obtained through high-throughput sequencing, where high-throughput sequencing can be whole genome or simplified genome sequencing.
  • high-throughput sequencing can be whole genome or simplified genome sequencing.
  • the genome sequences of at least 10 isolates are generally used as references.
  • the step S1 specifically includes:
  • step lengths can also be used when screening on the reference genome with a window of 100-300 bp.
  • the step size is 1 bp, which is conducive to comprehensive screening.
  • the multiple PCR amplification primers labeled with MNP are designed by primer design software.
  • the primer design follows that the primers do not interfere with each other. All primers can be combined into a primer pool for multiple PCR amplification, that is, all designed primers can be used in one amplification reaction. normal expansion.
  • the method for detecting the MNP markers is to amplify all the MNP markers at one time through multiplex PCR, sequence the amplified products through second-generation high-throughput sequencing, analyze the sequencing data, and evaluate the primers according to the detected markers. Combination compatibility.
  • Example 2 Threshold setting and performance evaluation of MNP markers and primers identifying Yersinia pestis
  • the Y. pestis nucleotide standard with known copy number was added to human genomic DNA to prepare mock samples of Y. pestis with 1 copy/reaction, 10 copies/reaction and 100 copies/reaction.
  • an equal volume of sterile water was set as a blank control.
  • a total of 4 samples were constructed, and 3 replicate libraries were constructed per day for each sample, and were tested continuously for 4 days, that is, 12 sets of sequencing data were obtained for each sample, as shown in Table 2.
  • the thresholds for contamination of the quality control system and detection of target pathogens were established, and the detection was evaluated. Method reproducibility, accuracy, sensitivity.
  • the kit can stably detect more than 8 MNP sites in samples with 10 copies/reaction, and detect at most 1 MNP site in a few samples with 0 copies/reaction.
  • the kit can clearly distinguish samples with 10 copies/reaction and 0 copies/reaction, and has technical stability and detection sensitivity as low as 10 copies/reaction.
  • the reproducibility and accuracy of the MNP marker detection method for the detection of Y. pestis were evaluated. Specifically, 12 sets of data of 100 copies of samples were compared in pairs. The results are shown in Table 3.
  • the kit can accurately and sensitively detect Yersinia pestis as low as 10 copies/reaction.
  • the sequence aligned to Y. pestis can be detected in 1 copy/reaction sample, covering at least 1 MNP marker.
  • the sequence of Yersinia pestis was also detected. Due to the extreme sensitivity of the MNP marker detection method, data contamination during the detection process can easily lead to false positives. Therefore, the following quality control plan was formulated in this example.
  • the quality control plan is as follows:
  • the amount of sequencing data is greater than 4.5 million bases. The calculation is based on the fact that the number of MNP markers detected in each sample is 15, and the length of a sequencing fragment is 300 bases. Therefore, when the data volume is greater than 4.5 million bases, most samples can be guaranteed to cover each marker in one experiment. The number of sequencing fragments reaches 1000 times, ensuring accurate analysis of the base sequence of each MNP marker.
  • Blank control noise index P nc/Nc, wherein nc and Nc respectively represent the number of sequenced fragments and the total number of sequenced fragments of Yersinia pestis in the blank control.
  • the signal index of the test sample S nt/Nt, wherein nt and Nt respectively represent the number of sequenced fragments and the total number of sequenced fragments of Yersinia pestis in the test sample.
  • the mean value of the noise index of Yersinia pestis in the blank control is 0.04%, while the mean value of the signal index in the sample of 1 copy is 0.29%, the signal-to-noise ratio of the sample of 1 copy and the blank control
  • the average value of is 6.9, therefore, the present invention stipulates that when the signal-to-noise ratio is greater than 10 times, it can be judged that the contamination in the detection system is acceptable.
  • the average value of the signal-to-noise ratio of 10 copies of the sample and the blank control is 65.3, and in the 12 sets of data of 10 copies/reaction, at least 8 MNP markers can be stably detected, accounting for the total markers 53.3%. Therefore, in the case of ensuring the accuracy, this standard stipulates that the positive judgment standard of Yersinia pestis is: when the signal-to-noise ratio of Yersinia pestis in the sample is greater than 30, and the marker detection rate is greater than or equal to 30%, it is determined that plague has been detected in the sample Bacillus nucleotides. It can be seen that the kit provided by the present invention can sensitively detect Yersinia pestis as low as 10 copies/reaction.
  • the samples were named S1-S6 in sequence, and the sequencing average of each sample was The coverage factor was up to 1300 times, and all 15 MNP markers could be detected for each strain (Table 5). Compare the fingerprints of the 6 strains in pairs, and the results are shown in Table 5. The fingerprints of S2 and S4 are consistent, and the fingerprints of the other 4 strains are consistent, indicating that during the long-term reproduction and preservation process, due to genetic variation Or genetic drift, where there is variation between strains of the same name.
  • kits to identify genetic variation between strains by detecting MNP markers can be used to ensure the genetic consistency of the same named Yersinia pestis strains in different laboratories, thereby ensuring the comparability of research results, which is of great significance to the scientific research of Yersinia pestis Significance.
  • the Yersinia pestis group As a group organism, some individuals within the Yersinia pestis group mutate, making the group no longer homozygous and forming a heterogeneous heterozygous group, which affects the stability and consistency of the microbial phenotype, especially in the test.
  • Such variants appear as alleles outside of the marker's major genotype when the population is tested for molecular markers. When the variant individual has not yet accumulated, it only accounts for a very small part of the population, showing a low frequency allele type. Low-frequency allele types are often mixed with technical errors, making them difficult to distinguish with existing techniques.
  • the present invention detects highly polymorphic MNP markers. The technical error rate of MNP markers is significantly lower than that of SNP markers, based on the fact that multiple errors are less likely to occur simultaneously than one error.
  • the authenticity evaluation of the secondary allelic type in this embodiment is carried out as follows: first, the allelic type with strand preference (the ratio of the number of sequencing sequences covered on the DNA double strand) is excluded according to the following rules: the strand preference is greater than 10 times, or more than 5 times different from the strand preference of the main allele type.
  • e max (n 1) and e max (n ⁇ 2) of 1.03% and 0.0994%, respectively, were obtained from the frequencies of all minor alleles detected at 930 homozygous MNP markers.
  • the nucleotides of the two strains with different genotypes are divided into the following 8 ratios: 1/1000, 3/1000, 5/1000, 7/1000, 1/100, 3/100, 5/100, 7/100 was mixed to prepare artificial heterozygous samples, each sample was detected 3 times, and a total of 24 sequencing data were obtained.
  • markers of heterozygous genotypes were detected in 24 artificial heterozygous samples, indicating that the developed MNP marker detection method of Yersinia pestis is in Suitability for detecting genetic variation within strain populations.
  • the DNA of all strains or samples used to construct the Y. pestis DNA fingerprint database was extracted by conventional CTAB method and commercial kits, and the quality of the DNA was detected by agarose gel and ultraviolet spectrophotometer. If the ratio of the absorbance value of the extracted DNA at 260nm to 230nm is greater than 2.0, the ratio of the absorbance value at 260nm to 280nm is between 1.6 and 1.8, the main band of DNA electrophoresis is obvious, and there is no obvious degradation and RNA residue, it means that the genomic DNA has reached Relevant quality requirements, follow-up experiments can be carried out.
  • the main genotype of each marker of each strain was obtained to form the MNP fingerprint of each strain.
  • the obtained MNP fingerprints of each bacterial strain were entered into the database file to form the MNP fingerprint database of Yersinia pestis.
  • the constructed MNP fingerprint database is based on the gene sequence of the detected strains, so it is compatible with all high-throughput sequencing data, and has the characteristics of being fully co-constructed, shared, and updateable at any time. Compare the MNP fingerprints of each strain obtained by each test with the established MNP fingerprint database, and enter the MNP fingerprints of strains with differences in main genotypes into the constructed MNP fingerprint database to achieve real-time update of the database and co-construction and sharing.
  • Embodiment 6 application in fine typing of Yersinia pestis
  • the above six Yersinia pestis strains were detected by using the primer combination and the MNP marker detection method, and the MNP fingerprints of each strain were obtained.
  • the DNA fingerprints of each strain were compared in pairs, and then compared with the published reference sequence of Yersinia pestis and the constructed fingerprint database, and the strains with the closest fingerprints were screened.
  • the ones that are the same as the existing fingerprint database are existing variants, and those that have a main genotype difference in at least one MNP marker are new variants to achieve fine typing of Yersinia pestis.

Abstract

Disclosed in the present invention are an MNP marker combination of Yersinia pestis, a primer pair combination, a kit, and an application thereof. The MNP marker site refers to a genome region which is screened on a genome of Yersinia pestis, is distinguished from other species, and has a plurality of nucleotide polymorphism inside the species. A combination of marker sites MNP-1 to MNP-15 is comprised. The specific nucleotide sequences of the 15 marker sites are as shown in SEQ ID NO. 1 to SEQ ID NO. 15. The primer pair combination comprises 15 pairs of primers. The specific nucleotide sequences of the 15 pairs of primers are as shown as SEQ ID NO. 16 to SEQ ID NO. 45. The MNP marker combination can be used for identification and typing of Yersinia pestis, construction of a DNA fingerprint database, genetic variation detection, etc.

Description

一种鼠疫杆菌的MNP标记组合、引物对组合、试剂盒及其应用A kind of MNP marker combination of Yersinia pestis, primer pair combination, kit and application thereof 技术领域technical field
本发明实施例涉及生物技术领域,特别涉及一种鼠疫杆菌的MNP标记组合、引物对组合、试剂盒及其应用。The embodiment of the present invention relates to the field of biotechnology, in particular to a MNP marker combination of Yersinia pestis, a primer pair combination, a kit and applications thereof.
背景技术Background technique
鼠疫杆菌(Yersinia pestis)属于耶尔森氏菌属,它是引起烈性传染病鼠疫的病原菌,同时也是致死性细菌战剂之一。鼠疫是我国传染病防治法规定的甲类传染病,具有很强的传染性和死亡率,人通过接触感染的动物、食入污染的食物或被鼠蚤类动物叮咬等途径而感染。Yersinia pestis (Yersinia pestis) belongs to the genus Yersinia, it is the pathogenic bacteria that causes the severe infectious disease plague, and it is also one of the deadly bacterial warfare agents. Plague is a Class A infectious disease stipulated in my country's Law on the Prevention and Control of Infectious Diseases. It is highly contagious and fatal. People are infected through contact with infected animals, eating contaminated food, or being bitten by rats and fleas.
另外,鼠疫杆菌作为群体生物,在和宿主、环境的互作中,鼠疫杆菌群体内个体也常常会发生变异,导致检测方法、防治方法的失效;对于鼠疫杆菌的实验室研究来说,这种变异也会导致不同实验室或同一实验室不同时期相同命名的菌株实际上并不相同,导致实验结果的不可重现和不可比较。因此,开发快速、准确的、可监测变异的鼠疫杆菌检测分析方法对于鼠疫杆菌的科学研究和防疫都具有重要意义。In addition, Yersinia pestis is a group organism, and in the interaction with the host and the environment, individuals in the Yersinia pestis group often mutate, resulting in the failure of detection methods and prevention methods; for laboratory research on Yersinia pestis, this Variation can also cause strains with the same name in different laboratories or in different periods of the same laboratory to be actually different, resulting in non-reproducible and non-comparable experimental results. Therefore, the development of a rapid, accurate, and variable-monitoring detection and analysis method for Yersinia pestis is of great significance for the scientific research and epidemic prevention of Yersinia pestis.
经典的鼠疫杆菌检测方法,包括分离培养、PCR技术、全基因组和宏基因组测序等,在时长、操作复杂度、检测通量、检测变异 的准确性和灵敏度、成本等方面存在一个或多个局限。融合超多重PCR扩增和高通量测序的靶向分子标记检测技术,可以在低微生物含量的样本中靶向的富集目标微生物,避免了全基因组和宏基因组测序带来的大量数据浪费和背景噪音,具有样本需要量少、诊断结果精确,节约数据量、检测低频变异的优势。Classical detection methods of Yersinia pestis, including isolation and culture, PCR technology, whole genome and metagenomic sequencing, etc., have one or more limitations in terms of time length, operational complexity, detection throughput, accuracy and sensitivity of detection of mutations, and cost. The targeted molecular marker detection technology that combines ultra-multiplex PCR amplification and high-throughput sequencing can enrich target microorganisms in samples with low microbial content, avoiding a large amount of data waste and background caused by whole genome and metagenomic sequencing Noise, which has the advantages of less sample requirement, accurate diagnosis results, saving data volume, and detecting low-frequency variation.
现有的靶向分子标记检测技术检测的分子标记主要包括SNP和SSR标记。SSR标记是公认的多态性最高的标记,但在微生物中数量少;SNP标记数量巨大,分布密集,是二态性标记,单个SNP标记的多态性不足以捕获微生物种群中潜在的等位基因多样性。因此,开发高多态性的新型分子标记及其检测技术,成为亟待解决的技术问题。The molecular markers detected by the existing targeted molecular marker detection technology mainly include SNP and SSR markers. SSR markers are recognized as the most polymorphic markers, but their number is small in microorganisms; SNP markers are huge in number, densely distributed, and are dimorphic markers, and the polymorphism of a single SNP marker is not enough to capture potential alleles in microbial populations genetic diversity. Therefore, the development of new molecular markers with high polymorphism and their detection technology has become an urgent technical problem to be solved.
本发明开发物种特异的新型分子标记-MNP标记。MNP标记是指在基因组上一段区域内由多个核苷酸引起的多态性标记。与SSR标记和SNP标记相比,MNP标记具有以下优势:(1)等位基因型丰富,单个MNP标记上有2 n种等位基因型,高于SSR和SNP;(2)物种区分能力强,只需要少量的MNP标记就能实现物种鉴定,减少了检测错误率。基于超多重PCR结合二代高通量测序技术检测MNP标记的MNP标记法具有以下优势:(1)输出的是碱基序列,无需平行实验,可构建标准化的数据库进行共享共用;(2)高效率,利用样品DNA条形码,突破测序样品数量的局限,可一次性对成百上千份样本的数万个MNP标记分型;(3)高灵敏度,利用多重PCR一次检测多个靶标,避免单个靶标扩增失败导致高的假阴性和低的灵敏 度;(4)高准确性,利用二代高通量测序仪对扩增产物测序数百次。 The present invention develops a species-specific novel molecular marker-MNP marker. MNP markers refer to polymorphic markers caused by multiple nucleotides in an upper region of the genome. Compared with SSR markers and SNP markers, MNP markers have the following advantages: (1) rich allelic types, with 2 n allele types on a single MNP marker, higher than SSR and SNP markers; (2) strong species discrimination ability , only a small amount of MNP markers are needed to achieve species identification, reducing the detection error rate. The MNP marker method based on ultra-multiplex PCR combined with next-generation high-throughput sequencing technology to detect MNP markers has the following advantages: (1) The output is base sequence, without parallel experiments, and a standardized database can be constructed for sharing; (2) High Efficiency, using sample DNA barcodes, breaking through the limitation of the number of sequencing samples, and can type tens of thousands of MNP markers in hundreds of samples at one time; (3) High sensitivity, using multiplex PCR to detect multiple targets at a time, avoiding single Target amplification failures lead to high false negatives and low sensitivity; (4) high accuracy, using a second-generation high-throughput sequencer to sequence the amplified product hundreds of times.
鉴于以上优点和特性,MNP标记及其检测技术MNP标记法可实现群体生物多等位基因型的分类与溯源,在病原微生物的鉴定、指纹数据库构建、遗传变异检测等方面都具有应用潜力。目前在微生物中,尚未有关于MNP标记的报道,也缺乏相应的技术。因此,亟需开发病原微生物鼠疫杆菌的MNP标记和检测引物。本发明所开发的标记和引物组合将用于制定病原体检测的国家标准(计划编号20201830-T-469),该国家标准将于2021年底发布。In view of the above advantages and characteristics, MNP marker and its detection technology MNP marker method can realize the classification and traceability of multi-allelic genotypes in populations, and has application potential in the identification of pathogenic microorganisms, fingerprint database construction, and genetic variation detection. At present, in microorganisms, there is no report on MNP labeling, and there is a lack of corresponding technology. Therefore, there is an urgent need to develop MNP markers and detection primers for the pathogenic microorganism Yersinia pestis. The combination of markers and primers developed in the present invention will be used to formulate national standards for pathogen detection (plan number 20201830-T-469), which will be released by the end of 2021.
发明内容Contents of the invention
本发明目的是提供一种鼠疫杆菌的MNP标记组合、引物对组合、试剂盒及其应用,可以对鼠疫杆菌进行鉴定和变异检测,具有多靶标、高通量、高灵敏和精细分型的效果。The purpose of the present invention is to provide a MNP marker combination, primer pair combination, kit and application of Yersinia pestis, which can identify and detect mutations of Yersinia pestis, and have the effects of multi-target, high throughput, high sensitivity and fine typing .
在本发明的第一方面,提供了一种鼠疫杆菌的MNP标记组合,所述MNP标记是指在鼠疫杆菌基因组上筛选的区分于其他物种且在物种内部具有多个核苷酸多态性的基因组区域,所述MNP标记组合包括鼠疫杆菌AL590842参考序列上MNP-1~MNP-15的15个标记。In the first aspect of the present invention, a combination of MNP markers of Yersinia pestis is provided, the MNP markers refer to the MNP markers that are screened on the Yersinia pestis genome to distinguish them from other species and have multiple nucleotide polymorphisms within the species In the genome region, the MNP marker combination includes 15 markers from MNP-1 to MNP-15 on the reference sequence of Yersinia pestis AL590842.
上述技术方案中的MNP-1~MNP-15标记的具体核苷酸序列如SEQ ID NO.1-SEQ ID NO.15所示,其中ID NO.16-SEQ ID NO.30为上引物,ID NO.31-SEQ ID NO.45为下引物。说明书表1进一步详细说明,表1中标注的所述MNP标记的起始和终止位置是基于表1 中参考序列AL590842确定的。The specific nucleotide sequence of the MNP-1~MNP-15 marker in the above technical scheme is shown in SEQ ID NO.1-SEQ ID NO.15, wherein ID NO.16-SEQ ID NO.30 is the upper primer, ID NO.31-SEQ ID NO.45 is the lower primer. Table 1 of the description further specifies that the start and end positions of the MNP marker marked in Table 1 are determined based on the reference sequence AL590842 in Table 1.
在本发明的第二方面,提供了一种用于检测所述MNP标记组合的多重PCR引物对组合,所述多重PCR引物对组合包括15对引物,具体的引物序列如SEQ ID NO.1-SEQ ID NO.30所示。In a second aspect of the present invention, there is provided a combination of multiple PCR primer pairs for detecting the MNP marker combination, the multiple PCR primer pair combination includes 15 pairs of primers, and the specific primer sequences are as SEQ ID NO.1- Shown in SEQ ID NO.30.
上述技术方案中,每个MNP标记的引物包括上引物和下引物,具体如说明书表1所示。In the above technical scheme, each MNP-labeled primer includes an upper primer and a lower primer, as shown in Table 1 of the specification.
在本发明的第三方面,提供了一种用于检测所述鼠疫杆菌MNP标记组合的检测试剂盒,所述试剂盒包括所述的引物对组合。In the third aspect of the present invention, a detection kit for detecting the Y. pestis MNP marker combination is provided, the kit includes the primer pair combination.
进一步地,所述试剂盒还包括多重PCR预混液。Further, the kit also includes a multiplex PCR master mix.
以及所述的鼠疫杆菌的MNP标记组合或所述的引物对组合或检测试剂盒在非疹断目的鼠疫杆菌定性检测中的应用,在制备鼠疫杆菌定性检测产品中的应用。And the application of the MNP marker combination of Yersinia pestis or the primer pair combination or detection kit in the qualitative detection of Yersinia pestis of non-diagnosed species, and the application in the preparation of qualitative detection products of Yersinia pestis.
在本发明的第四方面,提供了所述的鼠疫杆菌的MNP标记组合或者所述的多重PCR引物对组合或者所述的检测试剂盒在鼠疫杆菌的鉴定、DNA指纹数据库的构建、遗传变异检测中的应用。In the fourth aspect of the present invention, there is provided the MNP marker combination of Y. pestis or the combination of multiple PCR primer pairs or the detection kit in the identification of Y. pestis, the construction of DNA fingerprint database, and the detection of genetic variation. in the application.
以上所述的应用中,首先是获取待测样本的细菌总DNA;利用本发明的试剂盒对所述总DNA和空白对照进行第一轮多重PCR扩增,循环数不高于25个;对扩增产物进行纯化后,进行基于第二轮PCR扩增的样本标签和二代测序接头添加;对第二轮扩增产物纯化后定量;检测多个菌株时通过将第二轮扩增产物等量混合后进行高通量测序;测序结果比对到所述的鼠疫杆菌的参考序列上,获取在所述总DNA的检测序列数目和基因型数据。根据在所述总DNA和 所述空白对照获得的鼠疫杆菌测序序列数量和检出MNP标记的数目,对所述总DNA的测序数据进行数据质量控制和数据分析,获得检出MNP标记数目、覆盖每个所述MNP标记的测序序列数目和所述MNP标记基因型数据。In the above-mentioned application, at first be to obtain the bacterial total DNA of the sample to be tested; Utilize the kit of the present invention to carry out the first round of multiplex PCR amplification to the total DNA and the blank control, and the number of cycles is not higher than 25; After the amplified product is purified, add sample tags and next-generation sequencing adapters based on the second round of PCR amplification; quantify the second-round amplified product after purification; detect multiple strains by combining the second-round amplified product, etc. High-throughput sequencing was carried out after the amounts were mixed; the sequencing results were compared to the reference sequence of Yersinia pestis, and the number of detected sequences and genotype data in the total DNA were obtained. According to the number of sequenced sequences of Yersinia pestis and the number of detected MNP markers obtained in the total DNA and the blank control, data quality control and data analysis were performed on the sequencing data of the total DNA to obtain the number of detected MNP markers, coverage The sequence number of each MNP marker and the genotype data of the MNP marker.
当用于鼠疫杆菌鉴定时,根据在待测样品和空白对照中检出的鼠疫杆菌的测序序列数量和检出MNP位点的数目,进行质控后判定待测样品中是否含有鼠疫杆菌的核酸。其中,所述的质控方案和判定方法是以拷贝数已知的鼠疫杆菌的DNA为检测样本,评估所述试剂盒检测鼠疫杆菌的灵敏度、准确性和特异性,制定所述试剂盒检测鼠疫杆菌时的质控方案和判定方法。When used for the identification of Yersinia pestis, according to the number of sequencing sequences of Yersinia pestis detected in the sample to be tested and the blank control and the number of detected MNP sites, after quality control, it is determined whether the nucleic acid of Yersinia pestis is contained in the sample to be tested . Wherein, the quality control scheme and determination method use the DNA of Yersinia pestis with a known copy number as the detection sample, evaluate the sensitivity, accuracy and specificity of the kit to detect Yersinia pestis, and formulate the kit to detect plague The quality control scheme and determination method for bacillus.
当用于鼠疫杆菌遗传变异检测时,包括菌株间和菌株内部的遗传变异检测。菌株间的遗传变异检测包括利用所述的试剂盒和方法,获得待比较菌株各自在15个MNP标记的基因型数据。通过基因型比对,分析待比较菌株在所述15个MNP标记上的主基因型是否存在差异。若待比较菌株在至少一个MNP标记的主基因型存在变异,则判定两者存在遗传变异。作为一种备选方案,也可以通过单重PCR对待比较菌株的15个标记分别进行扩增,然后对扩增产物进行Sanger测序,获得序列后,对待比较菌株每个MNP标记的基因型进行比对。如果存在主基因型不一致的MNP标记,则待比较菌株之间存在变异。当检测菌株内部的遗传变异时,则通过统计模型判定在待测菌株所述的MNP标记是否检出主基因型以外的次基因型。若待测菌株在至少一个MNP标记存在次基因型,则判定待测菌株内部存 在遗传变异。When used for the detection of genetic variation of Yersinia pestis, it includes the detection of genetic variation between strains and within strains. The detection of genetic variation between strains includes using the above kit and method to obtain the genotype data of each of the 15 MNP markers of the strains to be compared. Through genotype comparison, analyze whether there are differences in the main genotypes of the strains to be compared on the 15 MNP markers. If there is a variation in at least one main genotype of the MNP marker in the strain to be compared, it is determined that there is a genetic variation between the two. As an alternative, it is also possible to amplify the 15 markers of the strain to be compared by single-plex PCR, and then perform Sanger sequencing on the amplified products. After obtaining the sequence, compare the genotype of each MNP marker of the strain to be compared. right. If there are MNP markers with inconsistent main genotypes, there is variation among the strains to be compared. When detecting the genetic variation within the strain, it is judged by statistical model whether the MNP markers in the strain to be tested detect sub-genotypes other than the main genotype. If the strain to be tested has a subgenotype at least one MNP marker, it is determined that there is genetic variation within the strain to be tested.
当用于构建鼠疫杆菌DNA指纹数据库时,将从样本中鉴定的鼠疫杆菌的所述MNP标记的基因型数据,录入数据库文件,构成鼠疫杆菌的DNA指纹数据库;每次鉴定不同的样本时,通过和所述鼠疫杆菌的DNA指纹数据库比对,鉴定样本中的鼠疫杆菌是否和数据库中的菌株在所述MNP标记存在主基因型(在一个MNP标记具有超过50%测序片段支持的基因型)的差异,在至少1个MNP标记存在主基因型差异的鼠疫杆菌即为新的变异类型,收录进DNA指纹数据库。When used to construct the Yersinia pestis DNA fingerprint database, the genotype data of the MNP marker of the Yersinia pestis identified from the sample is entered into the database file to form the DNA fingerprint database of the Yersinia pestis; when different samples are identified each time, by Compared with the DNA fingerprint database of Yersinia pestis, identify whether the Yersinia pestis in the sample and the strains in the database have a main genotype (a genotype supported by more than 50% sequencing fragments in an MNP marker) at the MNP marker Differences, Yersinia pestis with major genotype differences in at least one MNP marker is a new variant type, which is included in the DNA fingerprint database.
当用于鼠疫杆菌分型时,是对待测样本中的鼠疫杆菌进行鉴定,获得每个所述MNP位点的基因型;收集网上公开的鼠疫杆菌的基因组序列和已构建的鼠疫杆菌DNA指纹数据库组成鼠疫杆菌参考序列库;将待测样本中鼠疫杆菌的基因型和所述鼠疫杆菌的参考序列库进行比对,筛选遗传上一致或最接近的菌株,获得待测样本中鼠疫杆菌的分型。根据同所述参考序列库的比对结果,鉴定样品中的鼠疫杆菌是已有的型还是新的变型,实现对鼠疫杆菌的精细分型。When used for Yersinia pestis typing, it is to identify the Yersinia pestis in the sample to be tested, and obtain the genotype of each MNP site; collect the genome sequence of Yersinia pestis published on the Internet and the constructed DNA fingerprint database of Yersinia pestis Constitute the reference sequence library of Yersinia pestis; compare the genotype of Yersinia pestis in the sample to be tested with the reference sequence library of Yersinia pestis, screen the genetically consistent or closest strains, and obtain the type of Yersinia pestis in the sample to be tested . According to the comparison result with the reference sequence library, it is identified whether the Yersinia pestis in the sample is an existing type or a new variant, and the fine typing of the Yersinia pestis is realized.
与现有技术相比,本发明具有以下优点:Compared with the prior art, the present invention has the following advantages:
本发明提供了一种鼠疫杆菌的MNP标记组合、引物对组合、试剂盒及其应用。所提供的鼠疫杆菌的15个MNP标记和其引物组合,可进行多重PCR扩增,融合二代测序平台进行扩增产物的测序,满足对鼠疫杆菌进行高通量、高效率、高准确性和高灵敏度检测的需求,满足鼠疫杆菌标准的、可共享的指纹数据构建的要求;准确检 测鼠疫杆菌菌株间遗传变异的需求;鉴定鼠疫杆菌纯合和杂合的需求。The invention provides a MNP marker combination of Yersinia pestis, a primer pair combination, a kit and applications thereof. The provided 15 MNP markers of Yersinia pestis and their primer combinations can be used for multiplex PCR amplification, and the next-generation sequencing platform can be used to sequence the amplified products, which meets the needs of high-throughput, high-efficiency, high-accuracy and The demand for high-sensitivity detection meets the requirements for the construction of standard and shareable fingerprint data for Y. pestis; the need for accurate detection of genetic variation among Y. pestis strains; the need for identifying homozygous and heterozygous Y. pestis.
本发明在鼠疫杆菌领域属于首创,并未见相关文献报道;MNP标记主要基于参考序列开发,根据已报道的鼠疫杆菌代表小种的重测序数据可以挖掘大规模的区分于其他物种、在鼠疫杆菌物种内部多态、两侧序列保守的MNP标记;通过MNP标记两侧的保守序列可以设计适用于于多重PCR扩增的MNP标记检测引物;再根据标准品的测试结果,可筛选出一套多态性最大、特异性高的一套MNP标记、兼容性最好的引物组合以及检测方法,并用于鼠疫杆菌的检测、DNA指纹图谱构建,菌株内和菌株间遗传变异检测以及其他相关应用中,为鼠疫杆菌的科学研究、科学监测和防治提供技术支撑。The present invention is the first in the field of Yersinia pestis, and there are no related literature reports; MNP markers are mainly developed based on reference sequences, and according to the resequencing data of the reported Yersinia pestis representative races, large-scale identifications of Yersinia pestis species, which are different from other species, can be mined MNP markers with polymorphic and conserved sequences on both sides of the species; MNP marker detection primers suitable for multiplex PCR amplification can be designed through the conserved sequences on both sides of the MNP markers; and a set of multiple A set of MNP markers with the largest morphism and high specificity, the most compatible primer combination and detection method, and used in the detection of Yersinia pestis, the construction of DNA fingerprints, the detection of genetic variation within and between strains and other related applications, Provide technical support for scientific research, scientific monitoring and control of Yersinia pestis.
附图说明Description of drawings
图1为MNP标记多态性原理图;Figure 1 is a schematic diagram of MNP marker polymorphism;
图2为鼠疫杆菌MNP标记的筛选和引物设计流程图;Fig. 2 is the screening and primer design flowchart of Yersinia pestis MNP marker;
图3为MNP标记的检测流程图;Fig. 3 is the detection flowchart of MNP mark;
具体实施方式Detailed ways
为了便于理解本发明,下面结合附图和具体实施例,对本发明进行更详细的说明。附图中给出了本发明的较佳的实施例。但是,本发明可以以许多不同的形式来实现,并不限于本说明书所描述的实施例。相反地,提供这些实施例的目的是使对本发明的公开内容的理解更加透彻全面。In order to facilitate the understanding of the present invention, the present invention will be described in more detail below in conjunction with the accompanying drawings and specific embodiments. Preferred embodiments of the invention are shown in the accompanying drawings. However, the present invention can be implemented in many different forms and is not limited to the embodiments described in this specification. On the contrary, these embodiments are provided to make the understanding of the disclosure of the present invention more thorough and comprehensive.
需要说明的是,除非另有定义,本说明书所使用的所有的技术和科学术语与属于本发明的技术领域的技术人员通常理解的含义相同。在本发明的说明书中所使用的术语只是为了描述具体的实施例的目的,不是用于限制本发明。It should be noted that, unless otherwise defined, all technical and scientific terms used in this specification have the same meaning as commonly understood by those skilled in the technical field of the present invention. Terms used in the description of the present invention are only for the purpose of describing specific embodiments, and are not used to limit the present invention.
除非另有特别说明,本发明实施例中用到的各种原材料、试剂、仪器和设备等,均可通过市场购买得到或者可通过现有方法制备得到。Unless otherwise specified, various raw materials, reagents, instruments and equipment used in the examples of the present invention can be purchased from the market or prepared by existing methods.
实施例1 鼠疫杆菌MNP标记组合的筛选和多重PCR扩增引物的设计Example 1 Screening of Yersinia pestis MNP marker combinations and design of multiplex PCR amplification primers
S1、鼠疫杆菌MNP标记组合的筛选S1, Screening of Yersinia pestis MNP marker combinations
基于网上公开的419个鼠疫杆菌不同分离株的基因组完整或部分序列,通过序列比对,获得15个MNP标记。对于网上不存在基因组数据的物种,也可以通过高通量测序获得待检测微生物物种代表小种的基因组序列信息,其中高通量测序可以是全基因组或简化基因组测序。为了保证所筛选标记的多态性,一般使用至少10个分离株的基因组序列作为参考。Based on the complete or partial genome sequences of 419 different isolates of Y. pestis published online, 15 MNP markers were obtained through sequence alignment. For species that do not have genomic data on the Internet, the genome sequence information of representative races of the microbial species to be detected can also be obtained through high-throughput sequencing, where high-throughput sequencing can be whole genome or simplified genome sequencing. In order to ensure the polymorphism of the selected markers, the genome sequences of at least 10 isolates are generally used as references.
筛选的15个MNP标记如表1所示:The 15 MNP markers screened are shown in Table 1:
表1 所述MNP标记以及检测引物在参考序列上的起始位置The starting positions of the MNP markers and detection primers on the reference sequence in Table 1
Figure PCTCN2021129167-appb-000001
Figure PCTCN2021129167-appb-000001
Figure PCTCN2021129167-appb-000002
Figure PCTCN2021129167-appb-000002
所述步骤S1具体包括:The step S1 specifically includes:
选择所述鼠疫杆菌的一个代表株的基因组序列作为参考基因组,将所述基因组序列和所述参考基因组进行序列比对,获得所述鼠疫杆菌各菌株的单核苷酸多态性标记;selecting the genome sequence of a representative strain of Y. pestis as a reference genome, and comparing the genome sequence with the reference genome to obtain the single nucleotide polymorphism markers of each strain of Y. pestis;
在所述参考基因组上,以100-300bp为窗口,以1bp为步长进行窗口平移,筛选获得多个候选MNP标记区域,其中,所述候选MNP标记区域含有≥2个所述单核苷酸变异标记,且两端各30bp的序列上均不存在所述单核苷酸多态性标记;On the reference genome, use 100-300bp as the window, and perform window translation with 1bp as the step size, and screen to obtain multiple candidate MNP marker regions, wherein the candidate MNP marker regions contain ≥ 2 of the single nucleotides Variation markers, and the single nucleotide polymorphism markers do not exist on the 30bp sequences at both ends;
在所述候选多核苷酸多态性标记区域中筛选区分度DP≥0.2的区域作为MNP标记;其中,DP=d/t,t是在所述候选多核苷酸多态性标记区域中所有小种两两比较时的比较对数,d是在所述候选多核苷酸多态性标记区域中至少两个单核苷酸多态性差异的样品对数。In the candidate polynucleotide polymorphic marker region, the region with a discrimination degree DP≥0.2 is selected as the MNP marker; wherein, DP=d/t, and t is all the small polynucleotide polymorphic marker regions in the candidate polynucleotide d is the logarithm of comparisons of at least two single nucleotide polymorphisms in the region marked by the candidate polynucleotide polymorphism.
作为一种可选的实施方式,在所述参考基因组上,以100-300bp为窗口进行筛选时,也可选用其他步长,本实施方式采用步长为1bp,有利于全面的筛选。As an optional implementation, other step lengths can also be used when screening on the reference genome with a window of 100-300 bp. In this embodiment, the step size is 1 bp, which is conducive to comprehensive screening.
S2、多重PCR扩增引物的设计S2, the design of multiple PCR amplification primers
通过引物设计软件设计所述MNP标记的多重PCR扩增引物,引物设计遵循引物间互不干扰,所有引物可以组合成引物池进行多重PCR扩增,即所有设计的引物可以在一个扩增反应中均正常扩增。The multiple PCR amplification primers labeled with MNP are designed by primer design software. The primer design follows that the primers do not interfere with each other. All primers can be combined into a primer pool for multiple PCR amplification, that is, all designed primers can be used in one amplification reaction. normal expansion.
S3、引物组合的检测效率评估S3. Evaluation of detection efficiency of primer combinations
所述MNP标记的检测方法是通过多重PCR对所有MNP标记一次性进行扩增,通过二代高通量测序对扩增产物进行测序,对测序数据进行分析,根据检出的标记评价所述引物组合的兼容性。The method for detecting the MNP markers is to amplify all the MNP markers at one time through multiplex PCR, sequence the amplified products through second-generation high-throughput sequencing, analyze the sequencing data, and evaluate the primers according to the detected markers. Combination compatibility.
使用拷贝数已知的鼠疫杆菌DNA,加入到人基因组DNA中,制备成1000拷贝/反应的模板,通过所述的MNP标记检测方法进行检测,构建4个重复的测序文库,根据检测结果对所设计的引物组合进行筛选,最终筛选获得本发明提供的在4个文库中都能高效检出的15个MNP标记、以及兼容性最好的15个MNP标记的引物对组合,具体如表1所示。Use Yersinia pestis DNA with a known copy number, add it to human genomic DNA, prepare a template of 1000 copies/reaction, detect it by the MNP marker detection method, construct 4 repeated sequencing libraries, and perform the sequencing according to the detection results. The designed primer combinations were screened, and finally the combination of 15 MNP markers provided by the present invention that could be detected efficiently in the 4 libraries and the 15 MNP markers with the best compatibility were finally screened, specifically as shown in Table 1 Show.
实施例2 所述MNP标记和引物鉴定鼠疫杆菌的阈值设置和性能评 估Example 2 Threshold setting and performance evaluation of MNP markers and primers identifying Yersinia pestis
1、MNP标记检测试剂盒检测鼠疫杆菌的灵敏度和稳定性评估1. Evaluation of the sensitivity and stability of the MNP marker detection kit for the detection of Yersinia pestis
本实施例中,将拷贝数已知的鼠疫杆菌核苷酸标准品加入到人基因组DNA中,制备1拷贝/反应、10拷贝/反应和100拷贝/反应的鼠疫杆菌模拟样本。同时设置的等体积的无菌水作为空白对照。共计4个样本,每个样本每天构建3个重复文库,连续检测4天,即每个样本获得12组测序数据,具体如表2所示。根据在12次重复实验中,在空白对照和鼠疫杆菌核苷酸标准品中检出的鼠疫杆菌MNP标记的测序片段数和标记数,制定质控体系污染和目标病原体检出的阈值,评估检测方法的重现性、准确性、灵敏度。In this example, the Y. pestis nucleotide standard with known copy number was added to human genomic DNA to prepare mock samples of Y. pestis with 1 copy/reaction, 10 copies/reaction and 100 copies/reaction. At the same time, an equal volume of sterile water was set as a blank control. A total of 4 samples were constructed, and 3 replicate libraries were constructed per day for each sample, and were tested continuously for 4 days, that is, 12 sets of sequencing data were obtained for each sample, as shown in Table 2. According to the number of sequenced fragments and markers of Y. pestis MNP markers detected in the blank control and Y. pestis nucleotide standards in 12 repeated experiments, the thresholds for contamination of the quality control system and detection of target pathogens were established, and the detection was evaluated. Method reproducibility, accuracy, sensitivity.
MNP标记的检测流程如图3所示。The detection process of MNP markers is shown in Figure 3.
表2 鼠疫杆菌的MNP标记法的检测灵敏度、稳定性分析Table 2 Detection sensitivity and stability analysis of Yersinia pestis MNP labeling method
Figure PCTCN2021129167-appb-000003
Figure PCTCN2021129167-appb-000003
如表2所示,所述试剂盒能在10拷贝/反应的样本中稳定的检出8个以上MNP位点,而在0拷贝/反应的少数样本中最多检出1 个MNP位点,所述试剂盒能够明显区分10拷贝/反应和0拷贝/反应的样品,具有技术稳定性和低至10拷贝/反应的检测灵敏度。As shown in Table 2, the kit can stably detect more than 8 MNP sites in samples with 10 copies/reaction, and detect at most 1 MNP site in a few samples with 0 copies/reaction. The kit can clearly distinguish samples with 10 copies/reaction and 0 copies/reaction, and has technical stability and detection sensitivity as low as 10 copies/reaction.
2、MNP标记检测试剂盒检测鼠疫杆菌的重现性和准确性评估2. Evaluation of the reproducibility and accuracy of the MNP marker detection kit for the detection of Yersinia pestis
基于两次重复中,共同检出标记的基因型是否可重现,评估MNP标记检测方法检测鼠疫杆菌的重现性和准确性。具体地,对100拷贝样品的12组数据分别进行两两比较,结果如表3所示,主基因型存在差异的MNP标记数目都为0;依据2次重复实验间可重现的基因型认为是准确的原则,准确率a=1-(1-r)/2=0.5+0.5r,r代表重现率,即主基因型可重现的标记数目占共有标记数目的比率。本项目重现性试验中每个样品不同文库间、不同建库批次间MNP标记主基因型的差异对数为0,重现率r=100%,准确率a=100%。基于此,所述试剂盒能够准确、灵敏地检测低至10拷贝/反应的鼠疫杆菌。Based on whether the genotypes of the co-detected markers were reproducible in the two replicates, the reproducibility and accuracy of the MNP marker detection method for the detection of Y. pestis were evaluated. Specifically, 12 sets of data of 100 copies of samples were compared in pairs. The results are shown in Table 3. The number of MNP markers with differences in main genotypes is 0; It is the principle of accuracy, the accuracy rate a=1-(1-r)/2=0.5+0.5r, r represents the recurrence rate, that is, the ratio of the number of reproducible markers of the main genotype to the number of common markers. In the reproducibility test of this project, the logarithm of the difference of the main genotype of the MNP marker between different libraries and different database construction batches of each sample is 0, the reproducibility rate r=100%, and the accuracy rate a=100%. Based on this, the kit can accurately and sensitively detect Yersinia pestis as low as 10 copies/reaction.
表3 鼠疫杆菌MNP标记检出方法的重现性和准确率评估Table 3 Evaluation of the reproducibility and accuracy of the detection methods of Yersinia pestis MNP markers
Figure PCTCN2021129167-appb-000004
Figure PCTCN2021129167-appb-000004
Figure PCTCN2021129167-appb-000005
Figure PCTCN2021129167-appb-000005
3、MNP标记检测试剂盒检出鼠疫杆菌的阈值判定3. Threshold determination for the detection of Yersinia pestis by the MNP marker detection kit
如表2所示,在1个拷贝/反应的样本中能检出比对到鼠疫杆菌的序列,至少覆盖1个MNP标记。而在部分空白对照中也检出了鼠疫杆菌的序列。由于MNP标记检测方法的极度灵敏,因此检测过中的数据污染容易导致假阳性的产生。因此本实例中制定如下质控方案。As shown in Table 2, the sequence aligned to Y. pestis can be detected in 1 copy/reaction sample, covering at least 1 MNP marker. In some blank controls, the sequence of Yersinia pestis was also detected. Due to the extreme sensitivity of the MNP marker detection method, data contamination during the detection process can easily lead to false positives. Therefore, the following quality control plan was formulated in this example.
质控方案具体如下:The quality control plan is as follows:
1)测序数据量大于4.5百万碱基。测算依据是每个样品检测MNP标记的数目是15个,一条测序片段的长度是300个碱基,所以当数据量大于4.5百万碱基时,大部分样品一次实验可以保证覆盖每个标记的测序片段数量达到1000倍,保证对每个MNP标记碱基序列的精准分析。1) The amount of sequencing data is greater than 4.5 million bases. The calculation is based on the fact that the number of MNP markers detected in each sample is 15, and the length of a sequencing fragment is 300 bases. Therefore, when the data volume is greater than 4.5 million bases, most samples can be guaranteed to cover each marker in one experiment. The number of sequencing fragments reaches 1000 times, ensuring accurate analysis of the base sequence of each MNP marker.
2)根据测试样品中的鼠疫杆菌的信号指数S和空白对照中鼠疫杆菌的噪音指数P判定污染是否可接受,其中:2) Determine whether the pollution is acceptable according to the signal index S of Yersinia pestis in the test sample and the noise index P of Yersinia pestis in the blank control, wherein:
空白对照噪音指数P=nc/Nc,其中nc和Nc分别代表空白对照中,鼠疫杆菌的测序片段的数量和总测序片段数量。Blank control noise index P=nc/Nc, wherein nc and Nc respectively represent the number of sequenced fragments and the total number of sequenced fragments of Yersinia pestis in the blank control.
测试样品的信号指数S=nt/Nt,其中nt和Nt分别代表测试样品中,鼠疫杆菌的测序片段的数量和总测序片段数量。The signal index of the test sample S=nt/Nt, wherein nt and Nt respectively represent the number of sequenced fragments and the total number of sequenced fragments of Yersinia pestis in the test sample.
3)计算测试样品中MNP标记的检出率,指的是检出标记数和总设计标记数的比值。3) Calculate the detection rate of MNP markers in the test sample, which refers to the ratio of the number of detected markers to the total number of designed markers.
表4 待测样品中鼠疫杆菌的信噪比Table 4 The signal-to-noise ratio of Yersinia pestis in the samples to be tested
Figure PCTCN2021129167-appb-000006
Figure PCTCN2021129167-appb-000006
如表4所示,鼠疫杆菌在空白对照中的噪音指数平均值是0.04%,而在1个拷贝的样品中的信号指数平均值是0.29%,1个拷贝的样品和空白对照的信噪比的平均值是6.9,因此,本发明规定当信噪比大于10倍时,可判定检测体系中的污染是可接受的。As shown in Table 4, the mean value of the noise index of Yersinia pestis in the blank control is 0.04%, while the mean value of the signal index in the sample of 1 copy is 0.29%, the signal-to-noise ratio of the sample of 1 copy and the blank control The average value of is 6.9, therefore, the present invention stipulates that when the signal-to-noise ratio is greater than 10 times, it can be judged that the contamination in the detection system is acceptable.
如表4所示,在10个拷贝的样品和空白对照的信噪比的平均值是65.3,在10拷贝/反应的12组数据中,能稳定的检出至少8个MNP标记,占总标记的53.3%。因此,在保证准确性的情况下,本标准规定鼠疫杆菌阳性判定标准是:当样品中鼠疫杆菌的信噪比大于30,且标记检出率大于等于30%时,判定样本中检出了鼠疫杆菌的核苷酸。可见,本发明所提供的试剂盒能灵敏的检测到低至10拷 贝/反应的鼠疫杆菌。As shown in Table 4, the average value of the signal-to-noise ratio of 10 copies of the sample and the blank control is 65.3, and in the 12 sets of data of 10 copies/reaction, at least 8 MNP markers can be stably detected, accounting for the total markers 53.3%. Therefore, in the case of ensuring the accuracy, this standard stipulates that the positive judgment standard of Yersinia pestis is: when the signal-to-noise ratio of Yersinia pestis in the sample is greater than 30, and the marker detection rate is greater than or equal to 30%, it is determined that plague has been detected in the sample Bacillus nucleotides. It can be seen that the kit provided by the present invention can sensitively detect Yersinia pestis as low as 10 copies/reaction.
4、MNP标记检测方法检测鼠疫杆菌的特异性评估4. Evaluation of the specificity of the MNP marker detection method for the detection of Yersinia pestis
人为的将鼠疫杆菌和结核分枝杆菌、不动杆菌属菌株、百日咳鲍特菌、霍氏鲍特菌、肺炎衣原体、肺炎支原体、EB病毒、流感嗜血杆菌、水痘带状疱疹病毒、巨细胞病毒、单纯疱疹病毒、人博卡病毒、肺炎克雷伯杆菌、军团菌属、卡他莫拉菌、铜绿假单胞菌、立克次氏体属、金黄色葡萄球菌、肺炎链球菌、酿脓链球菌的DNA按照等摩尔量的混在一起,制备混合模板,以内标DNA作为空白对照,采用本发明所提供的方法对混合模板中的鼠疫杆菌进行检测,进行3个重复实验。结果在3个重复中获得的测序序列都仅能比对到鼠疫杆菌的14个MNP位点。按照所述的质控方案和判定阈值进行分析后,在3个重复实验中都特异的检出鼠疫杆菌的核酸,表明所述MNP标记和所述试剂盒在复杂模板中检测鼠疫杆菌的高特异性。Artificial Yersinia pestis and Mycobacterium tuberculosis, Acinetobacter strains, Bordetella pertussis, Bordetella hallii, Chlamydia pneumoniae, Mycoplasma pneumoniae, Epstein-Barr virus, Haemophilus influenzae, varicella-zoster virus, cytomegalovirus Viruses, Herpes Simplex Virus, Human Boca Virus, Klebsiella pneumoniae, Legionella, Moraxella catarrhalis, Pseudomonas aeruginosa, Rickettsia, Staphylococcus aureus, Streptococcus pneumoniae, Streptococcus pneumoniae The DNA of Streptococcus pyogenes was mixed together in equimolar amounts to prepare a mixed template, and the internal standard DNA was used as a blank control, and the method provided by the present invention was used to detect Yersinia pestis in the mixed template, and three repeated experiments were carried out. Results The sequencing sequences obtained in the three replicates could only be aligned to 14 MNP sites of Y. pestis. After analysis according to the described quality control scheme and judgment threshold, the nucleic acid of Yersinia pestis was specifically detected in three repeated experiments, indicating that the MNP marker and the kit have high specificity in detecting Yersinia pestis in complex templates sex.
实施例3、鼠疫杆菌菌株间的遗传变异检测Example 3, Detection of Genetic Variation Between Yersinia pestis strains
利用所述的试剂盒和MNP标记检测方法对湖北省疾控预防控制中心提供的同一个鼠疫杆菌菌株不同时期的6份子代菌株进行检测,样本依次命名为S1-S6,每个样品的测序平均覆盖倍数达1300倍,每个菌株均可以检出全部15个MNP标记(表5)。将6个菌株的指纹图谱进行两两比对,结果如表5所示,S2和S4的指纹图谱一致,其他4份的指纹图谱保持一致,表明在长期的繁殖和保存过程中,由于遗传变异或遗传漂移,相同命名的菌株存在菌株间变异。Using the kit and the MNP marker detection method to detect 6 progeny strains of the same Yersinia pestis strain in different periods provided by the Hubei Provincial Center for Disease Control and Prevention, the samples were named S1-S6 in sequence, and the sequencing average of each sample was The coverage factor was up to 1300 times, and all 15 MNP markers could be detected for each strain (Table 5). Compare the fingerprints of the 6 strains in pairs, and the results are shown in Table 5. The fingerprints of S2 and S4 are consistent, and the fingerprints of the other 4 strains are consistent, indicating that during the long-term reproduction and preservation process, due to genetic variation Or genetic drift, where there is variation between strains of the same name.
所述的试剂盒通过检测MNP标记鉴定菌株间遗传变异的应用可以用于保证不同实验室相同命名鼠疫杆菌菌株的遗传一致性,从而保证研究结果的可比较性,这对于鼠疫杆菌的科学研究具有重要意义。The application of the kit to identify genetic variation between strains by detecting MNP markers can be used to ensure the genetic consistency of the same named Yersinia pestis strains in different laboratories, thereby ensuring the comparability of research results, which is of great significance to the scientific research of Yersinia pestis Significance.
表3 6个鼠疫杆菌的检测分析Table 3 Detection and analysis of 6 Yersinia pestis
Figure PCTCN2021129167-appb-000007
Figure PCTCN2021129167-appb-000007
实施例4、鼠疫杆菌菌株内部的遗传变异检测Example 4, Detection of Genetic Variations in Yersinia pestis Strains
作为群体生物,鼠疫杆菌群体内部部分个体发生变异,使群体不再纯合,形成异质的杂合群体,影响尤其是试验用微生物表型的稳定性和一致性。这种变异体在对群体进行分子标记检测时,表现为标记的主基因型外的等位基因型。当变异个体还未累积时,只占群体的极少部分,表现为低频率的等位基因型。低频率的等位基因型往往和技术错误混在一起,导致现有技术难以区分。本发明检测的是高多态性的MNP标记。基于多个错误同时发生的几率低于一个错 误发生的几率,MNP标记的技术错误率显著低于SNP标记。As a group organism, some individuals within the Yersinia pestis group mutate, making the group no longer homozygous and forming a heterogeneous heterozygous group, which affects the stability and consistency of the microbial phenotype, especially in the test. Such variants appear as alleles outside of the marker's major genotype when the population is tested for molecular markers. When the variant individual has not yet accumulated, it only accounts for a very small part of the population, showing a low frequency allele type. Low-frequency allele types are often mixed with technical errors, making them difficult to distinguish with existing techniques. The present invention detects highly polymorphic MNP markers. The technical error rate of MNP markers is significantly lower than that of SNP markers, based on the fact that multiple errors are less likely to occur simultaneously than one error.
本实施例次等位基因型的真实性评估按如下进行:首先按照以下规则排除具有链偏好性(在DNA双链上覆盖的测序序列数的比值)的等位基因型:链偏好性大于10倍,或者与主等位基因型的链偏好性之差大于5倍。The authenticity evaluation of the secondary allelic type in this embodiment is carried out as follows: first, the allelic type with strand preference (the ratio of the number of sequencing sequences covered on the DNA double strand) is excluded according to the following rules: the strand preference is greater than 10 times, or more than 5 times different from the strand preference of the main allele type.
不存在链偏好性的基因型基于表6测序序列数目和比例判定其真实性。表6列出了基于BINOM.INV函数计算在α=99.9999%的概率保障下,e max(n=1)和e max(n≥2)分别为1.03%和0.0994%时,在各个标记中次等位基因型测序序列数目的临界值,只有次等位基因型的测序序列数目超过临界值时判定为真实的次等位基因型。当存在多个候选次等位基因时,对各候选等位基因型的P值进行多重校正,FDR<0.5%的候选等位基因判定是真实的次等位基因型。 The authenticity of genotypes without strand preference was determined based on the number and proportion of sequenced sequences in Table 6. Table 6 lists the calculations based on the BINOM.INV function under the probability guarantee of α=99.9999%, when e max (n=1) and e max (n≥2) are 1.03% and 0.0994%, respectively, in each marker The critical value of the sequence number of the allele type, only when the sequence number of the secondary allele type exceeds the critical value, it is determined as the real secondary allele type. When there are multiple candidate minor alleles, the P value of each candidate allele type is multiple-corrected, and the candidate alleles with FDR<0.5% are judged to be true minor allele types.
表6涉及到的参数e max(n=1)和e max(n≥2)指的是携带n个SNP的错误等位基因的测序序列数占该标记总测序序列数的最高比例。e max(n=1)和e max(n≥2)分别为1.03%和0.0994%是根据在930个纯合MNP标记检测到的所有次等位基因型的频率获得。 The parameters e max (n=1) and e max (n≥2) involved in Table 6 refer to the highest ratio of the number of sequencing sequences carrying the wrong alleles of n SNPs to the total number of sequencing sequences of the marker. e max (n=1) and e max (n≥2) of 1.03% and 0.0994%, respectively, were obtained from the frequencies of all minor alleles detected at 930 homozygous MNP markers.
表6 部分测序深度下进行判定次等位基因型的临界值Table 6 The critical value for determining the suballelic genotype under partial sequencing depth
Figure PCTCN2021129167-appb-000008
Figure PCTCN2021129167-appb-000008
Figure PCTCN2021129167-appb-000009
Figure PCTCN2021129167-appb-000009
按照上述参数,将基因型存在差异的两个菌株的核苷酸按照以下8个比例1/1000,3/1000,5/1000,7/1000,1/100,3/100,5/100,7/100混合,制备人工杂合样本,每个样本检测3次重复,获得共计 24个测序数据。通过和所述两个菌株的MNP标记的基因型进行精准比对,在24个人工杂合样本中均检测到了存在杂合基因型的标记,说明了所开发的鼠疫杆菌的MNP标记检测方法在检测菌株群体内部遗传变异的适用性。According to the above parameters, the nucleotides of the two strains with different genotypes are divided into the following 8 ratios: 1/1000, 3/1000, 5/1000, 7/1000, 1/100, 3/100, 5/100, 7/100 was mixed to prepare artificial heterozygous samples, each sample was detected 3 times, and a total of 24 sequencing data were obtained. Through accurate comparison with the genotypes of the MNP markers of the two strains, markers of heterozygous genotypes were detected in 24 artificial heterozygous samples, indicating that the developed MNP marker detection method of Yersinia pestis is in Suitability for detecting genetic variation within strain populations.
实施例5 鼠疫杆菌DNA指纹数据库的构建Example 5 Construction of Yersinia pestis DNA fingerprint database
利用常规CTAB法、商业化试剂盒等方法提取用于构建鼠疫杆菌DNA指纹数据库的所有菌株或是样本的DNA,采用琼脂糖凝胶和紫外分光光度计检测DNA的质量。若所提取的DNA在260nm与230nm处的吸光度值的比值大于2.0,260nm与280nm吸光度值比值介于1.6与1.8之间,DNA电泳主带明显,无明显降解和RNA残留,则说明基因组DNA达到相关的质量要求,可进行后续实验。The DNA of all strains or samples used to construct the Y. pestis DNA fingerprint database was extracted by conventional CTAB method and commercial kits, and the quality of the DNA was detected by agarose gel and ultraviolet spectrophotometer. If the ratio of the absorbance value of the extracted DNA at 260nm to 230nm is greater than 2.0, the ratio of the absorbance value at 260nm to 280nm is between 1.6 and 1.8, the main band of DNA electrophoresis is obvious, and there is no obvious degradation and RNA residue, it means that the genomic DNA has reached Relevant quality requirements, follow-up experiments can be carried out.
将上述6个菌株的测序数据同参考基因型进行序列比对后,获得每个菌株每个标记的主基因型,形成每个菌株的MNP指纹图谱。将获得的每个菌株的MNP指纹图谱录入数据库文件,形成鼠疫杆菌的MNP指纹数据库。After comparing the sequence data of the above six strains with the reference genotype, the main genotype of each marker of each strain was obtained to form the MNP fingerprint of each strain. The obtained MNP fingerprints of each bacterial strain were entered into the database file to form the MNP fingerprint database of Yersinia pestis.
所构建的MNP指纹数据库基于检测的菌株的基因序列,因此和所有的高通量测序数据兼容,具有完全可共建共享、随时可更新的特征。将每次检测获得的每个菌株的MNP指纹图谱同基于已构建的MNP指纹数据库进行比对,将主基因型存在差异的菌株的MNP指纹图谱录入所构建的MNP指纹数据库,达到数据库的实时更新和共建共享。The constructed MNP fingerprint database is based on the gene sequence of the detected strains, so it is compatible with all high-throughput sequencing data, and has the characteristics of being fully co-constructed, shared, and updateable at any time. Compare the MNP fingerprints of each strain obtained by each test with the established MNP fingerprint database, and enter the MNP fingerprints of strains with differences in main genotypes into the constructed MNP fingerprint database to achieve real-time update of the database and co-construction and sharing.
实施例6、在鼠疫杆菌精细分型中的应用Embodiment 6, application in fine typing of Yersinia pestis
利用所述的引物组合和MNP标记检测方法对上述6份鼠疫杆菌菌株进行检测,获得了每个菌株MNP指纹图谱。将每个菌株的DNA指纹图谱进行两两比对后,再同公开的鼠疫杆菌的参考序列和构建的指纹数据库进行比对,筛选获得指纹图谱最接近的菌株。和已有指纹数据库相同的,为已有的变型,在至少一个MNP标记存在主基因型差异的,为新的变型,实现对鼠疫杆菌的精细分型。对6份鼠疫杆菌样本的检测表5所示,所检测的6份鼠疫杆菌分为2个型,分别和A112和NCTC5923株接近。因此,所述的方法对鼠疫杆菌的分辨率达到了单碱基的水平,可以实现对样本中鼠疫杆菌的精细分型。The above six Yersinia pestis strains were detected by using the primer combination and the MNP marker detection method, and the MNP fingerprints of each strain were obtained. The DNA fingerprints of each strain were compared in pairs, and then compared with the published reference sequence of Yersinia pestis and the constructed fingerprint database, and the strains with the closest fingerprints were screened. The ones that are the same as the existing fingerprint database are existing variants, and those that have a main genotype difference in at least one MNP marker are new variants to achieve fine typing of Yersinia pestis. Detection of 6 Yersinia pestis samples As shown in Table 5, the 6 Yersinia pestis detected were divided into 2 types, which were close to A112 and NCTC5923 strains respectively. Therefore, the resolution of the method for Yersinia pestis reaches the level of single base, and can realize the fine typing of Yersinia pestis in the sample.
最后,还需要说明的是,术语“包括”、“包含”或者其任何其他变体意在涵盖非排他性的包含,从而使得包括一系列要素的过程、方法、物品或者设备不仅包括那些要素,而且还包括没有明确列出的其他要素,或者是还包括为这种过程、方法、物品或者设备所固有的要素。Finally, it should also be noted that the term "comprises", "comprises" or any other variation thereof is intended to cover a non-exclusive inclusion such that a process, method, article or apparatus comprising a set of elements includes not only those elements, but also Other elements not expressly listed, or inherent to the process, method, article, or apparatus are also included.
尽管已描述了本发明实施例的优选实施例,但本领域内的技术人员一旦得知了基本创造性概念,则可对这些实施例作出另外的变更和修改。所以,所附权利要求意欲解释为包括优选实施例以及落入本发明实施例范围的所有变更和修改。Having described preferred embodiments of embodiments of the present invention, additional changes and modifications to these embodiments can be made by those skilled in the art once the basic inventive concept is appreciated. Therefore, the appended claims are intended to be construed to cover the preferred embodiment and all changes and modifications which fall within the scope of the embodiments of the present invention.
显然,本领域的技术人员可以对本发明实施例进行各种改动和变型而不脱离本发明实施例的精神和范围。这样,倘若本发明实施 例的这些修改和变型属于本发明实施例权利要求及其等同技术的范围之内,则本发明实施例也意图包含这些改动和变型在内。Apparently, those skilled in the art can make various changes and modifications to the embodiments of the present invention without departing from the spirit and scope of the embodiments of the present invention. In this way, if the modifications and variations of the embodiments of the present invention fall within the scope of the claims of the embodiments of the present invention and their equivalent technologies, the embodiments of the present invention are also intended to include these modifications and variations.
Figure PCTCN2021129167-appb-000010
Figure PCTCN2021129167-appb-000010
Figure PCTCN2021129167-appb-000011
Figure PCTCN2021129167-appb-000011
Figure PCTCN2021129167-appb-000012
Figure PCTCN2021129167-appb-000012
Figure PCTCN2021129167-appb-000013
Figure PCTCN2021129167-appb-000013
Figure PCTCN2021129167-appb-000014
Figure PCTCN2021129167-appb-000014
Figure PCTCN2021129167-appb-000015
Figure PCTCN2021129167-appb-000015
Figure PCTCN2021129167-appb-000016
Figure PCTCN2021129167-appb-000016
Figure PCTCN2021129167-appb-000017
Figure PCTCN2021129167-appb-000017
Figure PCTCN2021129167-appb-000018
Figure PCTCN2021129167-appb-000018
Figure PCTCN2021129167-appb-000019
Figure PCTCN2021129167-appb-000019
Figure PCTCN2021129167-appb-000020
Figure PCTCN2021129167-appb-000020

Claims (9)

  1. 一种鼠疫杆菌的MNP标记组合,其特征在于,所述MNP标记组合包括15个标记,具体核苷酸序列如SEQ ID NO.1-SEQ ID NO.30所示。A MNP marker combination of Yersinia pestis, characterized in that the MNP marker combination includes 15 markers, and the specific nucleotide sequences are shown in SEQ ID NO.1-SEQ ID NO.30.
  2. 一种用于检测权利要求1所述鼠疫杆菌MNP标记组合的多重PCR引物对组合,其特征在于,所述多重PCR引物对组合包括15对引物,具体的引物核苷酸序列如SEQ ID NO.1-SEQ ID NO.30所示。A multiplex PCR primer pair combination for detecting the Yersinia pestis MNP marker combination described in claim 1, characterized in that said multiplex PCR primer pair combination includes 15 pairs of primers, and the specific primer nucleotide sequence is as SEQ ID NO. Shown in 1-SEQ ID NO.30.
  3. 一种用于检测权利要求1所述鼠疫杆菌MNP标记组合的检测试剂盒,其特征在于,所述试剂盒包括权利要求2所述的引物对组合。A detection kit for detecting the MNP marker combination of Yersinia pestis according to claim 1, characterized in that the kit includes the primer pair combination according to claim 2.
  4. 根据权利要求3所述的检测试剂盒,其特征在于,所述试剂盒还包括多重PCR预混液。The detection kit according to claim 3, characterized in that the kit also includes a multiplex PCR master mix.
  5. 权利要求1所述的鼠疫杆菌的MNP标记组合或权利要求2所述的引物对组合或权利要求3-4任一所述的检测试剂盒在非诊断目的鼠疫杆菌定性检测中的应用。The application of the MNP marker combination of Y. pestis described in claim 1 or the primer pair combination described in claim 2 or the detection kit described in any one of claims 3-4 in the qualitative detection of Y. pestis for non-diagnostic purposes.
  6. 权利要求1所述的鼠疫杆菌的MNP标记组合或权利要求2所述的引物对组合或权利要求3-4任一所述的检测试剂盒在制备鼠疫杆菌定性检测产品中的应用。The application of the MNP marker combination of Y. pestis described in claim 1 or the primer pair combination described in claim 2 or the detection kit described in any one of claims 3-4 in the preparation of qualitative detection products for Y. pestis.
  7. 权利要求1所述的鼠疫杆菌的MNP标记组合或权利要求2所述的引物对组合或权利要求3-4任一所述的检测试剂盒在在检测鼠疫杆菌菌株内部和菌株间遗传变异中的应用。The MNP marker combination of Y. pestis described in claim 1 or the primer pair combination described in claim 2 or the detection kit described in any one of claims 3-4 in the detection of genetic variation within and between strains of Y. pestis application.
  8. 权利要求1所述的鼠疫杆菌的MNP标记组合或权利要求2 所述的引物对组合或权利要求3-4任一所述的检测试剂盒在构建鼠疫杆菌数据库中的应用。The application of the MNP marker combination of Y. pestis described in claim 1 or the primer pair combination described in claim 2 or the detection kit described in any one of claims 3-4 in constructing a Y. pestis database.
  9. 权利要求1所述的鼠疫杆菌的MNP标记组合或权利要求2所述的引物对组合或权利要求3-4任一所述的检测试剂盒在鼠疫杆菌精细分型检测中的应用。The application of the MNP marker combination of Y. pestis described in claim 1 or the primer pair combination described in claim 2 or the detection kit described in any one of claims 3-4 in fine typing detection of Y. pestis.
PCT/CN2021/129167 2021-11-06 2021-11-06 Mnp marker combination of yersinia pestis, primer pair combination, kit, and application thereof WO2023077489A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PCT/CN2021/129167 WO2023077489A1 (en) 2021-11-06 2021-11-06 Mnp marker combination of yersinia pestis, primer pair combination, kit, and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CN2021/129167 WO2023077489A1 (en) 2021-11-06 2021-11-06 Mnp marker combination of yersinia pestis, primer pair combination, kit, and application thereof

Publications (1)

Publication Number Publication Date
WO2023077489A1 true WO2023077489A1 (en) 2023-05-11

Family

ID=86240585

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2021/129167 WO2023077489A1 (en) 2021-11-06 2021-11-06 Mnp marker combination of yersinia pestis, primer pair combination, kit, and application thereof

Country Status (1)

Country Link
WO (1) WO2023077489A1 (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030027135A1 (en) * 2001-03-02 2003-02-06 Ecker David J. Method for rapid detection and identification of bioagents
US20090280471A1 (en) * 2001-03-02 2009-11-12 Ecker David J Methods for rapid identification of pathogens in humans and animals
CN101824468A (en) * 2009-12-31 2010-09-08 广州华峰生物科技有限公司 Primer group for detecting Yersinia pestis, rapid diagnosis kit and detection method
CN105950759A (en) * 2016-06-23 2016-09-21 中国检验检疫科学研究院 Kit for simultaneously detecting four pathogenic bacteria and non-diagnostic detection method thereof
CN112391483A (en) * 2019-08-13 2021-02-23 内蒙古自治区综合疾病预防控制中心 Nucleic acid sequence, kit and method for detecting plague bacillus by isothermal amplification and application

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030027135A1 (en) * 2001-03-02 2003-02-06 Ecker David J. Method for rapid detection and identification of bioagents
US20090280471A1 (en) * 2001-03-02 2009-11-12 Ecker David J Methods for rapid identification of pathogens in humans and animals
CN101824468A (en) * 2009-12-31 2010-09-08 广州华峰生物科技有限公司 Primer group for detecting Yersinia pestis, rapid diagnosis kit and detection method
CN105950759A (en) * 2016-06-23 2016-09-21 中国检验检疫科学研究院 Kit for simultaneously detecting four pathogenic bacteria and non-diagnostic detection method thereof
CN112391483A (en) * 2019-08-13 2021-02-23 内蒙古自治区综合疾病预防控制中心 Nucleic acid sequence, kit and method for detecting plague bacillus by isothermal amplification and application

Similar Documents

Publication Publication Date Title
CN113718057A (en) MNP (MNP protein) marker site of EB (Epstein-Barr) virus, primer composition, kit and application
CN113862384A (en) MNP (protein marker) marker locus of Francisella tularensis, primer composition, kit and application
WO2023077489A1 (en) Mnp marker combination of yersinia pestis, primer pair combination, kit, and application thereof
WO2023077486A1 (en) Mnp marker combination for mycoplasma pneumoniae, primer pair combination, kit, and use
WO2023077485A1 (en) Mnp marker combination of chlamydia pneumoniae, primer pair combination, kit, and application thereof
WO2023077487A1 (en) Adenovirus mnp marker combination, primer pair combination, kit and use thereof
WO2023077482A1 (en) Combination of mnp markers of mycobacterium tuberculosis, primer pair combination, kit, and uses of combination, primer pair combination and kit
WO2023077488A1 (en) Mnp marker combination of streptococcus pneumonia, primer pair combination, kit and uses thereof
CN114790486B (en) MNP (MNP) marking site of bacillus anthracis, primer composition, kit and application of MNP marking site
CN114790488B (en) MNP (MNP) marking site of staphylococcus aureus, primer composition, kit and application of MNP marking site
CN114277165B (en) MNP (MNP) marking combination of plague bacillus, primer pair combination, kit and application of MNP marking combination
CN114836550B (en) MNP (MNP) marking site of klebsiella pneumoniae, primer composition, kit and application of MNP marking site
CN114107562B (en) MNP (human parainfluenza virus) marker locus, primer composition, kit and application of MNP marker locus
CN115029453B (en) MNP (MNP) marking site of streptococcus pyogenes, primer composition, kit and application of MNP marking site
CN114015793B (en) MNP (MNP) marking site of rickettsia, primer composition, kit and application of MNP marking site
CN114107525B (en) MNP (MNP) marking site of pseudomonas aeruginosa, primer composition, kit and application of MNP marking site
CN115029452B (en) MNP (MNP) marking site of Legionella, primer composition, kit and application of MNP marking site
CN113862383B (en) MNP (MNP) marking site of bacillus subtilis, primer composition and application of MNP marking site
CN114790489B (en) MNP (MNP) marking site of haemophilus influenzae, primer composition, kit and application of MNP marking site
CN115029477B (en) MNP (MNP-associated protein) marker locus of human rhinovirus, primer composition, kit and application of MNP marker locus
CN115029454B (en) MNP (MNP) marking site of Moraxella catarrhalis, primer composition, kit and application of MNP marking site
CN114836572B (en) MNP (MNP) marker locus of paraenterovirus, primer composition, kit and application of MNP marker locus
CN114277163B (en) MNP (MNP) labeling combination of chlamydia pneumoniae, primer pair combination, kit and application of kit
WO2023077491A1 (en) Mnp marker combination, primer pair combination and kit of respiratory syncytial virus and use thereof
CN114277164B (en) MNP (MNP-associated protein) marking combination, primer pair combination, kit and application of MNP marking combination and primer pair combination

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 21963002

Country of ref document: EP

Kind code of ref document: A1